Balchem Corp

BCPC remains in a clear uptrend across both long- and medium-term horizons, supported by a Stage 2 advance and a recent Momentum Breakout on expanding volume. Short-term conditions are overextended and overbought, suggesting execution should be deferred. Optimal engagement zones lie near the confluence of the rising 9-, 21-, and 50-day EMAs, where pullbacks should be met with demand. Overall, patience for a corrective reset is warranted despite structural bullishness.

• ↑Q1 revenue of $271M (+8.1% YoY), net income up 8.7% to $40M, EBITDA margin at 27.4%.
• ↑Free cash flow of $34M enables disciplined capital allocation via dividends and share repurchases.
• ↓Raw material inflation in animal nutrition threatens margin sustainability.